Loading...
 
Toggle Health Problems and D

Statin pain reduces Vitamin D levels by 4 ng ( 9 studies) - Meta-analysis July 2021

Am J Cardiovasc Drugs. 2021 Jul 23. doi: 10.1007/s40256-021-00492-8   PDF costs $50
Qingtao Hou 1, Caishuang Pang 2, Yuqin Chen 3

VitaminDWiki

Statins and vitamin D   >25 major entries as of July 2021

If you really must take statins and they cause pain, vitamin D will relieve the pain - 2015
Apparently: Stains ==> less cholesterol ==> less pre-vitamin D ==> less vitamin D from sun

VitaminDWiki pages containing "STATIN" in title

Items found: 24
Title Modified
Statin pain reduces Vitamin D levels by 4 ng ( 9 studies) - Meta-analysis July 2021 23 Jul, 2021
Statin side-effects are reduced by Vitamin D – US patent Application – April 2019 14 Nov, 2019
Statin pain eliminated by 7100 IU vitamin D (50000 IU weekly) – July 2011 21 Jul, 2019
Most Profitable Pill in Medical History Is Based on Flawed Science (Statins) May 2019 02 Jun, 2019
Statins and vitamin D 14 Jul, 2018
Low-dose statin plaque formation stopped by Omega-3 – RCT Dec 2017 24 Jan, 2018
Statin-induced Myalgias corrected with 100000 weekly Vitamin D2 20 Jul, 2017
Statin use increased probability of diabetes in women by 48 percent – perhaps via vitamin D Jan 2012 19 Mar, 2017
Statin use increased probability of diabetes by 48 percent – perhaps via vitamin D Jan 2012 19 Mar, 2017
The statin Crestor dramatically increases levels of vitamin D in the blood – Jan 2012 17 May, 2016
Some statins increase skin cancer risk by 40 percent (reducing vitamin D levels) – Jan 2016 10 Jan, 2016
Theories on the interaction between statins and vitamin D – 2012 10 Jan, 2016
If you must take statins and want to avoid hardening of arteries, take vitamin K2 – RCT May 2015 22 May, 2015
One statin decreased vitamin D levels but the other did not – March 2010 14 Apr, 2015
Not all statins increase vitamin D levels – Dec 2010 14 Apr, 2015
Off topic – Hypertension and statin pain reduced by Coenzyme Q10 – 2010 26 Jan, 2015
Statins with low vitamin D increased chance of musculoskeletal pain by 2X – Jan 2015 29 Nov, 2014
Statin pain associated with 10 ng less vitamin D – meta-analysis Oct 2014 24 Oct, 2014
Diabetics have problems with low Magnesium , especially if taking statins – Aug 2013 08 May, 2014
Statin-induced Myalgias corrected with 100000 weekly Vitamin D 04 May, 2014
Off topic: Statins associated with increased cataracts (wonder about low vitamin D) - Sept 2013 29 Sep, 2013
Diabetics have problems with low Magnesium, especially if taking statins – Aug 2013 28 Aug, 2013
Breast cancer 2X more likely if have taken statins for 10 years – July 2013 11 Jul, 2013
Statins associated with 14X increase in Polymyalgia Rheumatica (a new disease) – Aug 2012 09 Nov, 2012

Background: Myopathy is the most widely reported statin-associated adverse event. Several studies have linked vitamin D deficiency with statin-related myopathy.

Objective: This meta-analysis aimed to investigate whether adult patients with statin-related myopathy have a lower 25-hydroxyvitamin D (25OHD) level than patients without myopathy and whether statin-related myopathy in vitamin D-deficient patients can be improved by vitamin D supplementation.

Methods: PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials were searched until 28 September 2020. Original studies comparing the 25OHD levels of patients with and without myopathy or detecting the impact of vitamin D supplementation on statin-related muscular intolerance were included. Subgroup analyses based on the sample size and baseline 25OHD level were conducted.

Results: This meta-analysis, based on nine cohort studies with a total of 2906 patients, revealed that the 25OHD level of patients with statin-related myopathy was significantly lower than that of patients without myopathy [weighted mean difference - 4.17 ng/mL; 95% confidence interval (CI) - 7.70 to - 0.63; p = 0.021]. The overall analysis from another four studies with 446 patients who were previously vitamin D deficient and reported statin-related muscular intolerance showed that the pooled tolerance rate of statins improved to 89% (95% CI 8692; p < 0.001) after vitamin D supplementation.

Conclusions: The present meta-analysis provides evidence that low 25OHD level is associated with statin-related myopathy and that exogenous vitamin D supplementation can improve statin-related muscular intolerance associated with low 25OHD level in most cases. Our findings may provide useful insight for the prevention and treatment of statin-related myopathy.

References

  • Taylor BA, Thompson PD. Statin-associated muscle disease: advances in diagnosis and management. Neurotherapeutics. 2018;15(4):1006–17. - DOI
  • Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, et al. Statin safety and associated adverse events: a scientific statement from the American heart association. Arterioscler Thromb Vasc Biol. 2019;39(2):e38–81. - DOI
  • Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395–410. - DOI
  • Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding statin use in america and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6(3):208–15. - DOI
  • Sewright KA, Clarkson PM, Thompson PD. Statin myopathy: incidence, risk factors, and pathophysiology. Curr Atheroscler Rep. 2007;9(5):389–96. - DOI
  • Domingues-Faria C, Boirie Y, Walrand S. Vitamin D and muscle trophicity. Curr Opin Clin Nutr Metab Care. 2017;20(3):169–74. - DOI
  • Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis. 2011;215(1):23–9. - DOI
  • Ovesjö ML, Skilving I, Bergman P, Rane A, Ekström L, Björkhem-Bergman L. Low vitamin D levels and genetic polymorphism in the vitamin D receptor are associated with increased risk of statin-induced myopathy. Basic Clin Pharmacol Toxicol. 2016;118(3):214–8. - DOI
  • Riche KD, Arnall J, Rieser K, East HE, Riche DM. Impact of vitamin D status on statin-induced myopathy. J Clin Transl Endocrinol. 2016;6:56–9. - PubMed - PMC
  • Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 1 Jun 2011
  • Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10. - DOI
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. - DOI
  • Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15(6):235–43. - DOI
  • LeBlanc ES, Zakher B, Daeges M, Pappas M, Chou R. Screening for vitamin D deficiency: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2015;162(2):109–22. - DOI
  • Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, et al. Low serum 25 (OH) vitamin D levels (< 32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2009;153(1):11–6. - DOI
  • Minissian M, Agarwal M, Shufelt C, Mehta PK, Waldman T, Lentz G, et al. Do women with statin-related myalgias have low vitamin D levels? BMC Res Notes. 2015;8:449. - DOI
  • Pennisi M, Bartolo GD, Malaguarnera G, Bella R, Lanza G, Malaguarnera M. Vitamin D serum levels in patients with statin-induced musculoskeletal pain. Dis Mark. 2019;2019:3549402. https://doi.org/10.1155/2019/3549402 . eCollection 2019.
  • Taşoğlu Ö, Kutsal YG, Taşoğlu İ, Özdemİr O, Erdoğanoğlu Y. Is Vitamin D deficiency a risk factor for the development of statin-induced myalgia in patients receiving statins? Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi. 2015;61(4):314–9. - DOI
  • Backes JM, Barnes BJ, Ruisinger JF, Moriarty PM. A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias. Atherosclerosis. 2011;218(1):247–9. - DOI
  • Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, et al. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS. 2017;31(5):681–8. - DOI
  • Linde R, Peng L, Desai M, Feldman D. The role of vitamin D and SLCO1B1*5 gene polymorphism in statin-associated myalgias. Dermatoendocrinology. 2010;2(2):77–84. - DOI
  • Ovesjö ML, Skilving I, Bergman P, Rane A, Ekström L, Björkhem-Bergman L. Low vitamin D levels and genetic polymorphism in the vitamin D receptor are associated with increased risk of statin-induced myopathy. Basic Clin Pharmacol Toxicol. 2015;118(3):214–8. - DOI
  • Palamaner SG, Ramos J, Thomas-Hemak L, Pancholy SB. Association of vitamin D and incident statin induced myalgia—a retrospective cohort study. PLoS ONE. 2014;9(2):e88877. - DOI
  • Riphagen IJ, van der Veer E, Muskiet FA, DeJongste MJ. Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D. Curr Med Res Opin. 2012;28(7):1247–52. - DOI
  • Mergenhagen K, Ott M, Heckman K, Rubin LM, Kellick K. Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review. Clin Ther. 2014;36(5):770–7. - DOI
  • Eisen A, Lev E, Iakobishvilli Z, Porter A, Brosh D, Hasdai D, et al. Low plasma vitamin D levels and muscle-related adverse effects in statin users. Isr Med Assoc J. 2014;16(1):42–5. - PubMed
  • Glueck CJ, Abuchaibe C, Wang P. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle. Med Hypotheses. 2011;77(4):658–61. - DOI
  • Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, et al. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin. 2011;27(9):1683–90. - DOI
  • Khayznikov M, Hemachrandra K, Pandit R, Kumar A, Wang P, Glueck CJ. Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation. N Am J Med Sci. 2015;7(3):86–93. - DOI
  • Jetty V, Glueck CJ, Wang P, Shah P, Prince M, Lee K, et al. Safety of 50,000–100,000 units of vitamin D3/week in vitamin D-deficient, hypercholesterolemic patients with reversible statin intolerance. N Am J Med Sci. 2016;8(3):156–62. - DOI
  • Bhattacharyya S, Bhattacharyya K, Maitra A. Possible mechanisms of interaction between statins and vitamin D. QJM. 2012;105(5):487–91. - DOI
  • Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3): 676. https://doi.org/10.3390/nu11030676 .
  • Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol. 2006;291(6):C1208–12. - DOI
  • Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, et al. Analysis of vitamin D levels in patients with and without statin-associated myalgia—a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 2015;178:111–6. - DOI
  • Pereda CA, Nishishinya MB. Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review. Reumatol Clín (Engl Ed). 2016;12(6):331–5. - DOI
  • Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J. 2010;103(7):690–2. - DOI
  • Gerrard G. Fatal statin-induced rhabdomyolysis in the Australian indigenous population and vitamin D replacement—new concepts. Endocr Rev 2011;32(3). https://www.embase.com/search/results?subaction=viewrecord&id=L70676666&...
  • Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA. The National Lipid Association’s Muscle Safety Expert P. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3 Suppl):58–71. - DOI
  • Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1-45. - PubMed
  • Stulc T, Ceška R, Gotto AM Jr. Statin intolerance: the clinician’s perspective. Curr Atheroscler Rep. 2015;17(12):69. - DOI
  • Camerino GM, De Bellis M, Conte E, Liantonio A, Musaraj K, Cannone M, et al. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin. Toxicol Appl Pharmacol. 2016;306:36–46. - DOI


Created by admin. Last Modification: Friday July 23, 2021 20:03:53 GMT-0000 by admin. (Version 8)
See any problem with this page? Report it (FINALLY WORKS)